Smart watches for heart rate assessment in atrial arrhythmias

Koshy, A.; Sajeev, J.; Nerlekar, Nitesh; Brown, Adam; Rajakariar, K.; Zureik, Mark; Wong, Maria M.; Roberts, L.; Street, Maryann; Cooke, Jennifer; Teh, A.

doi:10.1016/j.ijcard.2018.02.073

Cited by 109 publications

(83 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Utilising PPG‐based smart watches for detection or chronotropic assessment of arrhythmias, particularly atrial fibrillation (AF), has garnered interest from both clinicians and patients. However, there was only weak to modest agreement during AF with marked HR underestimation when compared with a criterion standard ECG . This is similar to the pulse deficit identified during manual pulse check in patients with AF.…”

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) supporting

confidence: 65%

“…However, there was only weak to modest agreement during AF with marked HR underestimation when compared with a criterion standard ECG. 5 This is similar to the pulse deficit identified during manual pulse check in patients with AF. Nevertheless, a HR of ≥100 b.p.m.…”

supporting

confidence: 75%

“…However, limitations of PPG include the underestimation of HR during sinus tachycardia and reduced accuracy during physical activity . Similar to medical grade PPG systems, two early iterations of SDP with integrated consumer grade PPG, Fit Bit Blaze (Fitbit Inc., San Francisco, CA, USA) and Apple Watch Series 1 (Apple Inc., Cupertino, CA, USA), demonstrated strong agreement with concurrent electrocardiogram (ECG)‐derived HR in sinus rhythm …”

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) mentioning

confidence: 97%

“…during atrial arrhythmia closely correlated with an ECG HR ≥ 100 b.p.m. and may warrant consideration of clinical review . The demonstrated accuracy is likely to deteriorate further in a real‐world setting.…”

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) mentioning

confidence: 99%

“…4 Similar to medical grade PPG systems, two early iterations of SDP with integrated consumer grade PPG, Fit Bit Blaze (Fitbit Inc., San Francisco, CA, USA) and Apple Watch Series 1 (Apple Inc., Cupertino, CA, USA), demonstrated strong agreement with concurrent electrocardiogram (ECG)-derived HR in sinus rhythm. 5 Utilising PPG-based smart watches for detection or chronotropic assessment of arrhythmias, particularly atrial fibrillation (AF), has garnered interest from both clinicians and patients. However, there was only weak to modest agreement during AF with marked HR underestimation when compared with a criterion standard ECG.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Wearable devices for cardiac arrhythmia detection: a new contender?

Sajeev

Koshy

Teh

2019

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

There has been increased consumer uptake of smart devices and wearable technology. They facilitate non‐invasive, ambulatory assessment of numerous cardiac indices, including the heart rate and rhythm. Several studies have reported on the utility and deficiencies of these devices in identifying and monitoring cardiac arrhythmias. The rapid uptake of these consumer devices has the potential to generate vast amounts of biometric data. This coupled with gaps in knowledge pertaining to the optimal management of conditions such as sub clinical atrial fibrillation, may result in unnecessary and expensive downstream testing. An improved understanding of this nascent field by the clinician is vital.

show abstract

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) supporting

confidence: 65%

supporting

confidence: 75%

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) mentioning

confidence: 97%

Section: Sensitivity and Specificity Of Smart Device Platforms (Sdp) mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Wearable devices for cardiac arrhythmia detection: a new contender?

Sajeev

Koshy

Teh

2019

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

show abstract

Evaluation of Cardiac Rhythm Abnormalities From Wearable Devices

2019

JAMA

View full text Add to dashboard Cite

Although direct-to-consumer wearable devices are potentially useful in detecting arrhythmias, clinicians should understand the limitations of these devices and be prepared for the influx of data that will derive from patients. Wearable devices initially used accelerometers to encourage physical activity and assess sleep but recently incorporated heart rate sensors to enable targeted heart rate fitness programs and evaluation of resting heart rates (as an indicator of physical fitness). Most devices estimate heart rate using photoplethysmographic (PPG) sensors that detect changes in tissue blood volume (caused by peripheral pulses) and measure using dedicated photodetectors and light-emitting diodes. Accurate measurements depend on adequate blood flow and skin contact and can be altered by patient or device movement, environmental conditions, and ectopic beats. Although most wearables can display real-time heart rates, retrospective analysis of heart rate trends may be limited and depend on the device and its respective application.Recently, Apple Watch incorporated an irregular rhythm notification feature that detects PPG-based irregularity at rest and can notify the user of potential atrial fibrillation (AF). 1

show abstract

Apple Watch® facilitates single‐session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia

Kasai

Sekiguchi

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

Heart rate information from a smartwatch can facilitate the diagnosis and treatment of SVT. Benefitting from long-term HR trends, we performed successful RF catheter ablation of coexisting AVNRT and AVRT. K E Y W O R D S accessory pathway and slow pathway ablation, Apple Watch®, dual supraventricular tachycardias, heart rate trend, syncope How to cite this article: Kasai Y, Kasai J, Sekiguchi Y, et al. Apple Watch® facilitates singlesession catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia. Clin Case Rep. 2021;9:e04702.

show abstract

Smart watches for heart rate assessment in atrial arrhythmias

Cited by 109 publications

References 8 publications

Wearable devices for cardiac arrhythmia detection: a new contender?

Wearable devices for cardiac arrhythmia detection: a new contender?

Evaluation of Cardiac Rhythm Abnormalities From Wearable Devices

Apple Watch® facilitates single‐session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia

Contact Info

Product

Resources

About